Description:

Oftentimes, startup founders position themselves to investors as having an addressable market that is much larger than reality. While having a sufficient market size is critical to successful fundraising, it is more important for founders to represent numbers that reflect a market they can truly capture.

Come hear Jamie Kasuboski, VP of OMX Ventures, discuss why getting the market size correct is critical to investors and how startup founders can calculate these more accurately using a bottom-up approach. Jamie will share best practices that help founders look beyond a given indication and understand their patient segments better. The seminar will offer practical advice and insight for Northwestern students, postdocs, and faculty, and founders who are trying to get this number right.

SPEAKER BIO:

Jamie Kasuboski is a Vice President with OMX Ventures. Prior to OMX, Jamie developed deep experience in early-stage Biotech investing and company creation while working on the investment team at RA Capital. He served on the Enara Bio, Avilar Therapeutics, and Endor Therapeutics board in that role. Before joining RA, he was a Director at Boehringer Ingelheim Venture Fund and Board Director of Tilos Therapeutics (acquired by Merck & Co.) and Rewind Therapeutics. He holds a B.S. in Biology with a minor in Chemistry from Hillsdale College and a Ph.D. in Molecular and Cellular Biology from the University of Notre Dame.

Registration required and lunch will be provided